Viewing nowCholestop Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
White Life Science Co., Ltd.

MFDS item code 201405077 · Approved 2014.10.31 · Insurance code 625200960
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication serves as an effective adjunctive therapy for patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are inadequate. It may also be used in conjunction with dietary therapy or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia to control blood cholesterol levels. It helps lower total cholesterol and LDL cholesterol in hypercholesterolemia patients, thereby slowing the progression of atherosclerosis. It is also used as an adjunctive therapy to reduce LDL cholesterol and apolipoprotein B levels in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. This medication is effective for patients with primary dysbetalipoproteinemia, assisting in the reduction of cardiovascular disease risk, strokes, myocardial infarctions, and the risk of arterial revascularization. It is used to improve various conditions related to hyperlipidemia and enhance cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dosage is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dosage may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 3. Older adults: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this drug 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dosage is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dosage for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Ages 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dosage should be adjusted individually according to the recommended treatment goal for each patient. Dosage adjustments should be made at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, it should not be administered to those with an allergy to its components, severe liver dysfunction, muscle diseases, patients taking certain immunosuppressants, patients with severe renal impairment, pregnant or breastfeeding women, and fertile women who do not use adequate contraception. Moreover, high doses of this medication are prohibited in patients prone to myopathy or rhabdomyolysis, and careful evaluation is required for patients with these risk factors before administration. This medication contains lactose and should not be used in patients with lactose intolerance or certain inherited metabolic disorders. Patients with a history of liver disease or those consuming alcohol excessively should undergo regular liver function tests before starting this medication and while on it. If patients have specific diseases such as hypothyroidism or nephrotic syndrome, those conditions should be treated prior to therapy. This medication may cause myalgia, myopathy, and rarely severe muscle damage, such as rhabdomyolysis; thus, if muscle pain or weakness occurs, patients should notify their physician immediately. Discontinuation of the medication is advised especially if markers of muscle damage are significantly elevated in blood tests. The medication should be stopped in case of acute severe illness or if severe muscle weakness develops, and some patients may experience serious side effects such as severe skin reactions, thus any abnormal skin symptoms should prompt immediate medical consultation. This medication may interact with various other drugs, so patients taking other medications must inform their doctor or pharmacist, especially caution is warranted when used in conjunction with certain antiviral medications, immunosuppressants, or fibrates. Women of childbearing potential must ensure proper contraception during treatment and should discontinue the medication immediately if pregnancy occurs. It is also advisable not to use this medication while breastfeeding. In case of overdose, there is no specific antidote, so symptomatic treatment should be administered, and liver function and muscle injury should be closely monitored. This medication can cause symptoms like dizziness, hence caution is advised during driving or operating machinery. Lastly, this medication may show higher body concentrations in Asians, necessitating dosage adjustments.
Hypersensitivity, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, fixed drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It should be kept away from excessively hot or cold places, preferably stored at room temperature, between 1 to 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
White Life Science Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.